Synapse
⌘+K
Synapse
PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
October 2, 2025

Supplementary Figure S4 from Targeting Myeloid Trem2 Reprograms the Immunosuppressive Niche and Potentiates Checkpoint Immunotherapy in NASH-Driven Hepatocarcinogenesis

View Full Paper
Ask AI
Bookmark
Share

Authors

ZWZiyi WangYZYu ZhangXLXiangdong Li

Discussion

Loading...

Member takes

Overview

Analysis shows that targeting myeloid trem2 influences NET formation in NASH, highlighting its role in immunotherapy.

Key Points

  • Targeting myeloid trem2 enhances the efficacy of checkpoint immunotherapy in hepatocarcinogenesis, suggesting a new therapeutic pathway.
  • The study reveals that myeloid trem2-driven NASH carcinogenesis is partially reliant on the formation of neutrophil extracellular traps (NETs).
  • Analysis of the immunosuppressive niche shows a reprogramming effect that may improve treatment outcomes in liver cancer.
  • The implications point toward the potential of novel immunotherapy strategies tailored for NASH-driven liver malignancies.

Cite This Study

Wang et al. (2025) studied this question.

synapsesocial.com/papers/68de68f183cbc991d0a2196bhttps://doi.org/10.1158/2326-6066.30255484
View Full Paper
Ask AI
Bookmark
Share